关注
Matthew Heng
Matthew Heng
R&D Scientist, BioCell Innovations Pte. Ltd.
在 biocell.com.sg 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD
D Mei, WSD Tan, W Liao, CKM Heng, WSF Wong
Pharmacological Research 161, 105223, 2020
152020
Angiotensin II type-2 receptor activation in alveolar macrophages mediates protection against cigarette smoke-induced chronic obstructive pulmonary disease
D Mei, W Liao, PXL Gan, QTN Tran, CCMY Chan, CKM Heng, WSF Wong
Pharmacological Research 184, 106469, 2022
122022
Active p38α causes macrovesicular fatty liver in mice
I Darlyuk-Saadon, C Bai, CKM Heng, N Gilad, WP Yu, PY Lim, ...
Proceedings of the National Academy of Sciences 118 (14), e2018069118, 2021
122021
Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?
CKM Heng, N Gilad, I Darlyuk-Saadon, WSF Wong, D Engelberg
Pharmacology & Therapeutics 235, 108153, 2022
62022
Expression of a constitutively active p38α mutant in mice causes early death, anemia, and accumulation of immunosuppressive cells
I Darlyuk‐Saadon, CKM Heng, C Bai, N Gilad, WP Yu, ...
The FEBS Journal 288 (13), 3978-3999, 2021
62021
Asynchronous Pattern of MAPKs’ Activity during Aging of Different Tissues and of Distinct Types of Skeletal Muscle
N Gilad, MP Mohanam, I Darlyuk-Saadon, CKM Heng, I Plaschkes, ...
International Journal of Molecular Sciences 25 (3), 1713, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–6